Zoetis expands board of directors

 

Zoetis Inc.'s board of directors has appointed William F. Doyle, a member of Pershing Square Capital Management's Investment Team, effective February 3.

With the addition of Mr. Doyle, the Zoetis Board will expand to ten directors. Zoetis and Pershing Square reached an agreement providing for Mr. Doyle's election as well as the election in the future of an additional independent director mutually acceptable to Zoetis and Pershing Square.

Mr. Doyle has more than 20 years of experience in the healthcare industry. He is an Investment Team member at Pershing Square Capital Management, L.P. He is also the co-founder and managing partner at WFD Ventures LLC, which has provided equity financing and industry expertise to medical device, pharmaceutical and healthcare technology companies since 2003. From 1995 to 1999, he served as an executive at Johnson & Johnson. Previously, Mr. Doyle worked as a consultant with McKinsey & Company in its global healthcare practice.